StockData

Cardlytics vs Viant Technology

CDLX and DSP side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CDLX and DSP compare

Viant Technology is the larger company, worth 82 times as much as Cardlytics ($796M against $9.7M).

Viant Technology grew revenue faster over the last twelve months (27.5% versus −25.3% for Cardlytics).

Viant Technology keeps more of each dollar of sales as profit, with a net margin of 1.9% compared with −20.8% at Cardlytics.

Viant Technology scores higher on the StockData Score (11 against 7 for Cardlytics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCDLXDSP
Size and price
Market cap$9.7M$796M
Share price$1.65$11.97
Change, 1 year−88.5%37.0%
Change, 5 years−99.8%7.2%
Beta (5Y)2.501.43
Employees275380
StockData Score
Total score711 (better)
Valuation score1 (better)0
Growth score02 (better)
Performance score13 (better)
Health score56 (better)
Dividend score00
Valuation
P/S0.1× (better)1.9×
P/B–6.9×
EV/EBITDA–28.6×
P/FCF–11.8×
FCF yield−74.1%8.5% (better)
Fair value–$8.71
Margin of safety–−37.5%
Growth
Revenue growth (TTM)−25.3%27.5% (better)
Revenue growth, 5Y average4.5%15.8% (better)
Net income growth (TTM)–321%
EPS growth, 5Y average–−55.5%
Profitability
Gross margin–44.7%
Operating margin−19.2%1.6% (better)
Net margin−20.8%1.9% (better)
FCF margin−4.1%16.3% (better)
Return on equity–11.2%
Financial health
Debt / equity–0.00
Net debt / EBITDA–−6.39
Current ratio1.822.20 (better)
Altman Z-score−8.243.49 (better)
Piotroski F-score67 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions29.6%18.4%
Insider net buying, 12 months−$406K (better)−$9.5M

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.